Day One Biopharmaceuticals (DAWN) Earnings Date & Reports
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DAWN is expected to report earnings to rise 15.34% to -33 cents per share on November 10
Q3'25
Est.
$-0.33
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
The last earnings report on August 05 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 497.56K shares outstanding, the current market capitalization sits at 624.83M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DAWN showed earnings on August 05, 2025. You can read more about the earnings report here.